AM2454
Development of a biodegradable implant for the delivery of GLP-1 agonists, indicated for the treatment of metabolic syndrome. The feasibility study is expected shortly.
read moreProducts
Development of a biodegradable implant for the delivery of GLP-1 agonists, indicated for the treatment of metabolic syndrome. The feasibility study is expected shortly.
read moreBiodegradable implant encapsulating dexamethasone for intravitreal use for 6 months. Glucocorticoid for the treatment of age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion.
read moreready-to-use applicator with 3 month implant
read moreready-to-use applicator for 1 month or 3 month implant
read moreWillkommen auf unserer neuen Website: amw-pharmaceuticals.com
Wir haben unser Logo aufgefrischt und eine neue Domain – aber sonst bleibt alles beim Alten: AMW steht weiterhin für das gleiche Team, die gleiche Qualität und das gleiche Engagement.
Vielen Dank für Ihren Besuch – wir freuen uns auf die Zukunft mit Ihnen!
Welcome to our new online home: amw-pharmaceuticals.com
We’ve refreshed our logo and updated our domain, but everything else you know and trust about AMW remains the same — same team, same quality, same dedication to excellence.
Thanks for visiting, and we’re excited to continue moving forward with you!